Atorvastatin Calcium Tablet
Product Images NDC 55111-124

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 55111-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Label for Atorvastatin Calcium Tablets, USP 80 mg, oral tablets in a 90-count package. The label includes dosing instructions, storage conditions, and manufacturer information for Dr. Reddy's Laboratories Limited. It features the proprietary name, strength, and quantity prominently alongside the NDC 55111-124-90.*

FDA Label Image

Container2 (Container2)

Label for Atorvastatin Calcium Tablets, USP 80 mg by Dr. Reddy's Laboratories Limited. The label states each tablet contains atorvastatin calcium equivalent to 80 mg atorvastatin and the package contains 90 tablets. It includes instructions to see the package insert for dosage, storage instructions at 20°C to 25°C, and dispensing in light-resistant containers. The package is marked Rx Only with an NDC 55111-124-90.*

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier cumulative incidence curve comparing Atorvastatin to placebo over approximately 3.5 years. The graph shows percent cumulative incidence on the y-axis and years on the x-axis, with Atorvastatin represented by a solid line and placebo by a dotted line, indicating lower incidence with Atorvastatin.*

FDA Label Image

Figure2 (Figure2)

A line graph comparing cumulative hazard percentages over a 5-year follow-up period for Atorvastatin and placebo groups. The x-axis represents time in years, while the y-axis shows the cumulative hazard percentage. Two lines illustrate the hazard trends for placebo (dashed line) and Atorvastatin (solid line), with a hazard ratio of 0.63 (95% CI 0.48-0.83) and a p-value of 0.001 noted on the chart.*

FDA Label Image

Figure3 (Figure3)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over 5 years, with two lines representing atorvastatin dosages of 10 mg and 80 mg. The x-axis shows time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) and p-value indicating statistical analysis.*

FDA Label Image

Structure (Structure)

Chemical structure of atorvastatin calcium, showing the arrangement of its molecular components including aromatic rings, hydroxyl groups, and calcium ion association.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.